☰

David A. Brott, Ph.D. - Publications

Affiliations: 
2006 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Toxicology, Pathology
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ebrahimi A, Raichlen JS, Pointon A, Gottfridsson C, Munley J, Hockings P, Cartwright J, Buss N, Wikström J, Gan LM, Whittaker A, Khalil A, George RT, Garkaviy P, Brott D. Drug-induced myocardial dysfunction - recommendations for assessment in clinical and pre-clinical studies. Expert Opinion On Drug Safety. 1-14. PMID 32064957 DOI: 10.1080/14740338.2020.1731471  0.339
2019 Roth SE, Avigan MI, Bourdet D, Brott D, Church R, Dash A, Keller D, Sherratt P, Watkins PB, Westcott-Baker L, Lentini S, Merz M, Ramaiah L, Ramaiah SK, Marie Stanley A, et al. Next Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development. Clinical Pharmacology and Therapeutics. PMID 31314926 DOI: 10.1002/Cpt.1571  0.399
2018 Brott DA, Goodman MJ, Hermann RP, Merz M, Calvo R, Poorkhalkali N, Kiazand A. Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations? Drug Design, Development and Therapy. 12: 2757-2773. PMID 30233139 DOI: 10.2147/Dddt.S173671  0.354
2015 Brott DA, Furlong ST, Adler SH, Hainer JW, Arani RB, Pinches M, Rossing P, Chaturvedi N. Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes. Drug Design, Development and Therapy. 9: 3191-8. PMID 26124642 DOI: 10.2147/DDDT.S78792  0.358
2014 Bendjama K, Guionaud S, Aras G, Arber N, Badimon L, Bamberger U, Bratfalean D, Brott D, David M, Doessegger L, Firat H, Gallas JF, Gautier JC, Hoffmann P, Kraus S, et al. Translation strategy for the qualification of drug-induced vascular injury biomarkers. Toxicologic Pathology. 42: 658-71. PMID 24771082 DOI: 10.1177/0192623314527644  0.507
2014 Brott DA, Adler SH, Arani R, Lovick SC, Pinches M, Furlong ST. Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers. Drug Design, Development and Therapy. 8: 227-37. PMID 24611000 DOI: 10.2147/Dddt.S54956  0.388
2014 Brott DA, Katein A, Thomas H, Lawton M, Montgomery RR, Richardson RJ, Louden CS. Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury. Toxicologic Pathology. 42: 672-83. PMID 24499802 DOI: 10.1177/0192623313518664  0.59
2013 Brott DA, Bentley P, Nadella MV, Thurman D, Fikes J, Cheatham L, McGrath F, Luo W, Kinter LB. Renal biomarker changes associated with hyaline droplet nephropathy in rats are time and potentially compound dependent. Toxicology. 303: 133-8. PMID 23159986 DOI: 10.1016/J.Tox.2012.11.003  0.354
2012 Brott DA, Richardson RJ, Louden CS. Evidence for the nitric oxide pathway as a potential mode of action in fenoldopam-induced vascular injury. Toxicologic Pathology. 40: 874-86. PMID 22549976 DOI: 10.1177/0192623312444027  0.587
2012 Desai K, Brott D, Hu X, Christianson A. A systems biology approach for detecting toxicity-related hotspots inside protein interaction networks. Journal of Bioinformatics and Computational Biology. 9: 647-62. PMID 21976381 DOI: 10.1142/S0219720011005707  0.316
2012 Chen Y, Brott D, Altekar M, Caccese R, Jonasson H, Ericson A, Pehrson R, Pinches M, Valentin J, Kinter L, Bialecki R. Concordance of drug-induced changes in renal excretory function between safety pharmacology and toxicology studies in rats Journal of Pharmacological and Toxicological Methods. 66: 205. DOI: 10.1016/J.Vascn.2012.08.165  0.354
2011 Chen Y, Brott D, Bentley P, Kamendi H, Campbell P, Kinter L, Bialecki R. An integrative assessment of drug-induced changes in kidney function and kidney injury Journal of Pharmacological and Toxicological Methods. 64: e59. DOI: 10.1016/J.Vascn.2011.03.203  0.425
2008 Brott D, Gould S, Jones H, Schofield J, Prior H, Valentin JP, Bjurstrom S, Kenne K, Schuppe-Koistinen I, Katein A, Foster-Brown L, Betton G, Richardson R, Evans G, Louden C. Biomarkers of drug-induced vascular injury. Toxicology and Applied Pharmacology. 207: 441-5. PMID 15982681 DOI: 10.1016/J.Taap.2005.04.028  0.629
2006 Louden C, Brott D, Katein A, Kelly T, Gould S, Jones H, Betton G, Valetin JP, Richardson RJ. Biomarkers and mechanisms of drug-induced vascular injury in non-rodents. Toxicologic Pathology. 34: 19-26. PMID 16507540 DOI: 10.1080/01926230500512076  0.614
2005 Brott DA, Jones HB, Gould S, Valentin JP, Evans G, Richardson RJ, Louden C. Current status and future directions for diagnostic markers of drug-induced vascular injury. Cancer Biomarkers : Section a of Disease Markers. 1: 15-28. PMID 17192029 DOI: 10.3233/Cbm-2005-1104  0.593
2003 Brott DA, Maher RJ, Parrish CR, Richardson RJ, Smith AK. Flow cytometric characterization of perfused human bone marrow cultures: identification of the major cell lineages and correlation with the CFU-GM assay. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 53: 22-7. PMID 12701129 DOI: 10.1002/cyto.a.10034  0.388
Show low-probability matches.